# US 2026/0062707 A1 · Composition for regulating production of interfering ribonucleic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062707 A1
- Document ID: US20260062707A1
- Status: Published application
- Kind: A1
- Application number: 18/821,573
- Filed: 2024-08-30
- Published: 2026-03-05
- Earliest claimed: 2024-08-30
- Assignees: Wyvern Pharmaceuticals Inc.
- Applicants: Wyvern Pharmaceuticals Inc.
- Inventors: Bradley G. THOMPSON
- Web page: https://patentgrep.com/patent/US20260062707A1

## CPC

- C12N 15/1138: {against receptors or cell surface proteins}
- C12N 15/86: Viral vectors
- C12N 2310/141: MicroRNAs, miRNAs
- C12N 2330/51: Specially adapted vectors
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The embodiments of the present disclosure relate to one or more compositions or methods that upregulate the production of one or more sequences of micro-interfering ribonucleic acid (miRNA). The sequences of miRNA may be complimentary to a sequence of target messenger RNA (mRNA) that encodes for translation of a target biomolecule, such as CXCR4. The miRNA can cause the target mRNA to be degraded or inactivated, thereby causing a decrease in bioavailability of the target biomolecule because it is degraded or inactivated by the miRNA. Decreasing the bioavailability of the target biomolecule within a subject that is administered the one or more compositions may address the afflictions experienced by the subject due to expression of the target biomolecule.

## Claims

### Claim 1

A composition that comprises a recombinant plasmid (RP) comprising a sequence of nucleotides that is SEQ ID NO: 2.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the RP is encapsulated in a protein coat, a lipid vesicle, or any combination thereof.

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

(canceled)
